咖啡在慢性肝病中的保护作用:专注于加工
Rofida Khalifa1, Khalid Al-Naamani2, Mohamed Elbadry3
1Tropical Medicine Department, Faculty of Medicine, Minia University, El Menia, Egypt.
Journal of viral hepatitis
|September 8, 2025
概括
定期喝咖啡可以降低慢性肝病 (CLD) 进展的风险. 对于肝脏健康的最佳益处是在每天摄入三到四杯时观察到的.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 慢性肝病 (CLD) 构成了全球重大健康负担.
- 咖啡消费越来越多地与各种肝脏疾病中减少了CLD进展有关.
- 咖啡中的生物活性化合物可能会产生肝保护作用.
研究的目的:
- 审查目前关于咖啡摄入量与CLD进展之间的逆相关性的证据.
- 探索咖啡肝脏保护作用背后的潜在机制.
- 检查咖啡加工对其健康益处的影响.
主要方法:
- 现有科学文献的叙述性审查.
- 对调查咖啡消费和肝病结果的研究分析.
- 探索拟议的生物途径和影响因素.
主要成果:
- 有证据表明,咖啡摄入量和CLD进展之间存在剂量依赖的反向关系.
- 对肝脏健康的最佳益处与每天摄入三到四杯咖啡有关.
- 潜在的机制包括肠肝轴调节,表观遗传调节和改善的肝酶.
结论:
- 咖啡摄入量代表了一种有希望的,可访问的策略,以减轻CLD负担.
- 需要进一步的研究来确定最佳的咖啡制备方法,以获得最大的益处.
- 咖啡中的生物活性化合物为预防肝病的公共卫生干预提供了潜力.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
217
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
217
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Hepatic Drug Excretion: Influencing Factors
533
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
533
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
216
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
216
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Liver Physiology
3.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.5K


